GlassScriptPhysician profile
David W Brandli
NPI 1356330260
$18,003.58
in general payments reported to CMS, 2019-2025
52 companies · $5,249 in 2025
The $5,249 reported for 2025 was more than what 91% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $810 · 2020: $814 · 2021: $976 · 2022: $1,084 · 2023: $4,534 · 2024: $4,536 · 2025: $5,249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,548 · Food and Beverage: $5,049 · Travel and Lodging: $1,632 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,547.50 |
| Food and Beverage | $5,049.45 |
| Travel and Lodging | $1,632.05 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $6,824.51 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Pfizer INC. | $1,630.46 | 2021-2025 | |
| Astellas Pharma US INC | $1,321.83 | 2019-2025 | Xtandi |
| Procept Biorobotics Corporation | $1,230.97 | 2025 | |
| Boston Scientific Corporation | $1,136.92 | 2019-2025 | Ams 700, Rezum Generator, Advance Xp |
| Kowa Pharmaceuticals America, INC. | $402.25 | 2022-2023 | Seglentis |
| Endo Pharmaceuticals INC. | $370.80 | 2019-2024 | Xiaflex, Aveed |
| Sumitomo Pharma America, INC. | $334.24 | 2023-2025 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $316.58 | 2023-2025 | |
| Antares Pharma, INC. | $301.06 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Zyla Life Sciences, INC. | $287.58 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $285.06 | 2021-2024 | |
| Teleflex LLC | $270.76 | 2022-2025 | Urolift, Barrigel |
| Tolmar, INC. | $259.07 | 2023-2025 | Jatenzo, Eligard, Rubraca |
| Convatec INC. | $251.87 | 2020-2023 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $248.75 | 2019-2025 | Provenge |
| Olympus America INC. | $194.60 | 2025 | Itind System |
| Merck Sharp & Dohme LLC | $188.14 | 2021-2023 | Lynparza, Keytruda, Welireg |
| Ferring Pharmaceuticals INC. | $181.65 | 2020-2025 | Adstiladrin |
| Verity Pharmaceuticals INC. | $173.01 | 2025 | Trelstar |
| Abbvie INC. | $147.85 | 2022-2025 | |
| Coloplast Corp | $136.13 | 2021-2024 | Titan |
| Bioprotect Medical, INC. | $135.80 | 2025 | Bioprotect Balloon Implant System |
| Abbott Laboratories | $133.59 | 2019-2022 | |
| Endo USA, INC. | $101.16 | 2024-2025 | Xiaflex, Aveed |
| Astrazeneca Pharmaceuticals LP | $97.79 | 2021 | |
| Progenics Pharmaceuticals, INC. | $82.40 | 2023-2025 | Pylarify |
| Axonics, INC. | $76.95 | 2022-2024 | Axonics |
| Medtronic USA, INC. | $66.82 | 2019-2020 | |
| Blue Earth Diagnostics | $65.33 | 2020-2021 | |
| Urovant Sciences INC | $64.39 | 2021-2022 | |
| Medtronic, INC. | $62.96 | 2021-2024 | Interstim |
| Acerus Pharmaceuticals Corporation | $55.78 | 2021-2022 | |
| Neotract INC. | $54.25 | 2019-2020 | |
| 180 Medical, INC. | $52.99 | 2020-2024 | Gentlecath |
| Clarus Therapeutics INC. | $47.71 | 2021 | |
| Laborie Medical Technologies Corp. | $42.70 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Cycle Pharmaceuticals INC | $41.56 | 2025 | Venxxiva |
| Myovant Sciences INC. | $39.61 | 2021 | |
| Profound Medical Corp. | $37.01 | 2025 | Tulsa-Pro |
| Telix Pharmaceuticals | $30.91 | 2025 | Illuccix |
| Pharmaand Gmbh | $29.70 | 2025 | Rubraca |
| Dentsply Ih INC. | $25.10 | 2020-2021 | |
| Ambu INC. | $24.70 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $22.13 | 2019 | |
| Novartis Pharmaceuticals Corporation | $21.89 | 2025 | |
| Myriad Genetic Laboratories, INC. | $19.25 | 2025 | Prolaris |
| Assertio Therapeutics, INC. | $17.23 | 2020 | |
| Allergan, INC. | $17.08 | 2019 | |
| Avadel Specialty Pharmaceuticals, LLC | $15.53 | 2019 | |
| Amgen INC. | $14.83 | 2019 | |
| Sun Pharmaceutical Industries INC. | $12.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Brandli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.